Literature DB >> 7926270

The effect of nitric oxide donors on insulin secretion, cyclic GMP and cyclic AMP in rat islets of Langerhans and the insulin-secreting cell lines HIT-T15 and RINm5F.

J M Cunningham1, J G Mabley, C A Delaney, I C Green.   

Abstract

The aim of this study was to investigate whether short-term treatment with nitric oxide donors could mimic cytokine inhibition of insulin secretion. We tested the nitric oxide generating compounds 3-morpholinosydnonimine (SIN-1), S-nitroso-N-penicillamine (SNAP), S-nitrosoglutathione and hydroxylamine for their ability to inhibit insulin secretion, raise cyclic GMP and lower cyclic AMP levels in isolated rat islets of Langerhans and the insulin-secreting cell lines HIT-T15 and RINm5F. In islets, all nitric oxide donors inhibited glucose-induced insulin secretion and raised cyclic GMP levels. SIN-1 and S-nitrosoglutathione also reduced cyclic AMP, while SNAP and hydroxylamine had no effect. Insulin secretion in HIT-T15 cells was inhibited by SIN-1, SNAP and hydroxylamine and in RINm5F cells by hydroxylamine. Inhibition of HIT-T15 and RINm5F cell insulin secretion was not accompanied by an increase in cyclic GMP levels. The degree of inhibition of insulin secretion was unrelated to the extent of release of nitric oxide by the compounds as measured by nitrite and nitrate production. More effective inhibition by S-nitrosoglutathione and hydroxylamine versus SIN-1 and SNAP may be related to intracellular versus extracellular site of nitric oxide generation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7926270     DOI: 10.1016/0303-7207(94)90093-0

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  11 in total

1.  Dual effect of nitric oxide on ATP-sensitive K+ channels in rat pancreatic beta cells.

Authors:  Takaaki Sunouchi; Kimiaki Suzuki; Koichi Nakayama; Tomohisa Ishikawa
Journal:  Pflugers Arch       Date:  2008-02-01       Impact factor: 3.657

2.  Interaction of the islet nitric oxide system with L-arginine-induced secretion of insulin and glucagon in mice.

Authors:  B Akesson; H Mosén; G Panagiotidis; I Lundquist
Journal:  Br J Pharmacol       Date:  1996-10       Impact factor: 8.739

Review 3.  The role of interleukin-1 in the pathogenesis of IDDM.

Authors:  T Mandrup-Poulsen
Journal:  Diabetologia       Date:  1996-09       Impact factor: 10.122

4.  Influence of nitric oxide modulators on cholinergically stimulated hormone release from mouse islets.

Authors:  B Aring;kesson; I Lundquist
Journal:  J Physiol       Date:  1999-03-01       Impact factor: 5.182

Review 5.  Peroxynitrite-driven mechanisms in diabetes and insulin resistance - the latest advances.

Authors:  K Stadler
Journal:  Curr Med Chem       Date:  2011       Impact factor: 4.530

6.  Nitric oxide and hydroperoxide affect islet hormone release and Ca(2+) efflux.

Authors:  B Akesson; I Lundquist
Journal:  Endocrine       Date:  1999-08       Impact factor: 3.633

7.  Constitutive nitric oxide synthases in rat pancreatic islets: direct imaging of glucose-induced nitric oxide production in beta-cells.

Authors:  Sachiko Nakada; Tomohisa Ishikawa; Yuri Yamamoto; Yukiko Kaneko; Koichi Nakayama
Journal:  Pflugers Arch       Date:  2003-10-15       Impact factor: 3.657

8.  Antioxidant enzyme activity and mRNA expression in the islets of Langerhans from the BB/S rat model of type 1 diabetes and an insulin-producing cell line.

Authors:  Louise A Sigfrid; James M Cunningham; Neil Beeharry; L A Håkan Borg; Alma L Rosales Hernandez; Carina Carlsson; Adrian J Bone; Irene C Green
Journal:  J Mol Med (Berl)       Date:  2004-03-09       Impact factor: 4.599

Review 9.  Dual Role of Nitric Oxide in Regulating the Response of β Cells to DNA Damage.

Authors:  Bryndon J Oleson; John A Corbett
Journal:  Antioxid Redox Signal       Date:  2017-11-10       Impact factor: 8.401

10.  Phosphodiesterase 5 inhibition improves beta-cell function in metabolic syndrome.

Authors:  Kevin D Hill; Aaron W Eckhauser; Annis Marney; Nancy J Brown
Journal:  Diabetes Care       Date:  2009-02-05       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.